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Studies were carried out to further characterize enhancer and promoter elements on the woodchuck hepatitis virus (WHV)
genome. We were able to confirm the existence of WHV promoters analogous to the major promoters of the related human
hepatitis B virus (HBV) and of an enhancer analogous to the recently described WHV E2 element (Ueda, K., Wei, Y., and
Ganem, D., Virology 217, 413, 1996). However, we were unable to identify an enhancer analogous to the E1 element of
(HBV), despite the fact that these two viruses share a high degree of sequence homology and genetic organization. Some
factor binding sites in the E1 region appeared to be conserved between the two viruses and may be required for the activity
of the overlapping X gene promoter of WHV. Others did not appear to be essential for WHV X gene promoter activity, and
their functional activity, if any, was not revealed. Our failure to detect a functional enhancer element in the region of WHV
homologous to the HBV E1 enhancer may indicate that (i) fundamental differences exist in transcriptional regulation of the
small circular genomes of WHV and HBV; (ii) WHV contains an E1 element which is functional in the context of the intact
viral genome, but which is unable to function in the context of the various expression constructs used in our experiments;
or (iii) correct regulation of WHV transcription via an E1 element is dependent upon transcription factors which are not
expressed in the liver-specific cell lines used in our experiments. q 1997 Academic Press
INTRODUCTION tumor formation by insertional mutagenesis, in which vi-
ral regulatory elements induce inappropriate transcrip-
Woodchuck hepatitis virus (WHV) is closely related to tion of host genes (Dejean et al., 1986; Fourel et al., 1990,
human hepatitis B virus (HBV), sharing many of its biolog- 1994; Wei et al., 1992; Etiemble et al., 1994). However,
ical and physical properties (Summers et al., 1978). More- despite the interest in WHV-induced liver cancers, only
over, like HBV in humans, WHV can cause chronic liver a limited amount is known about WHV transcription, ei-
disease and hepatocellular carcinoma in its natural host, ther in vivo or in cell culture. The approximate start and
the Eastern woodchuck (Marmota monax) (Summers et stop sites of some of the major WHV transcripts have
al., 1978; Popper et al., 1987). Comparison of HBV and been mapped or, in the case of the pregenome, can be
WHV genomes also reveals a striking similarity in the deduced from studies on the sequence of viral minus
number, size, location, and sequence of the open reading strand DNA (Moroy et al., 1985; Seeger et al., 1986; Ka-
frames (Galibert et al., 1982; Kodama et al., 1985). neko and Miller, 1988). An analysis of the X-gene pro-
An aspect of HBV that has been studied for many years moter has been reported (Sugata et al., 1994) and the
is transcription from the four viral promoters, and the role ability of the E2 domain to activate N-myc transcription
of the two viral enhancer elements, E1 and E2, in this has been evaluated (Ueda et al., 1996). However, the
process (Cattaneo et al., 1983; Malpiece et al., 1983; remainder of the WHV transcriptional elements have not
Roossinck et al., 1986; Siddiqui et al., 1986, 1987; Treinin been mapped, the effects of putative enhancer domains
and Laub, 1987; De-Medina et al., 1988; Antonucci and on viral promoters have not been determined, and little
Rutter, 1989; Honigwachs et al., 1989; Raney et al., 1989; else is known for certain about how expression of this
Yaginuma and Koike, 1989; Yee, 1989; Guo et al., 1991a,b, virus is controlled. We have therefore carried out studies
1993; Raney et al., 1991; Zhang et al., 1992; Yaginuma et of the major transcriptional control regions on the WHV
al., 1993; Ueda et al., 1996). One rationale for these stud- genome. These studies were conducted in various liver-
ies has been to obtain insights into liver-specific gene derived cell lines that have previously been used to study
expression. Another has been to test the hypothesis, HBV transcription. Our results suggest either that there
most studied in the woodchuck, but still resting largely are major differences between the transcriptional regula-
on circumstantial evidence, that integration of viral DNA tors of human and woodchuck genes or that WHV tran-
sequences into host chromosomes may contribute to scription, unlike HBV transcription, requires factors that
are not normally expressed in liver cell lines. Our studies
also point out the need to develop approaches for analyz-1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (215) 728-3616. E-mail: ws_mason@fccc.edu. ing viral gene expression in vivo, or in primary hepatocyte
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TABLE 1
Promoter and Enhancer Regions of HBV and Homologous Sequences of WHV Studied for Comparisona
Location
Region HBV WHV References
E1/E2 2284 –3155 2392–3251 Shaul et al., 1991; Yee 1989; Su and Yee, 1992
E1 2284 –2690 2392–2798 Shaul et al., 1985, 1991; Ben-Levy et al., 1989; Patel et al., 1989
E2/core promoter b 2998 –3155 3101–3251 Yee, 1989; Yuh and Ting, 1990; Wang et al., 1990; Chen et al., 1993
PreS promoter 583 –953 589–968 Antonucci and Rutter, 1989; Chang and Ting, 1989; Shaul 1991
S promoter 496 –980 1028–1595c Siddiqui et al., 1986; De-Medina et al., 1988; Raney et al., 1989; Shaul, 1991
X promoter 2539–2799 Treinin et al., 1987; Siddiqui et al., 1986b; Guo et al., 1991a; Zhang et al., 1992;
Yaginuma et al., 1993; Sugata et al., 1994
a Regions of HBV containing the indicated transcriptional regulatory elements and the homologous regions of WHV which were analyzed are
indicated. The 5* end of HBV E2 used in our constructs was as defined by Chen et al. (1993) (cf. Fig. 1), and lacked sequences that were suggested
by Yuh and Ting (1990) to be essential for E2 enhancer activity.
b The AUG of preCore, which maps within the core promoter, was placed in-frame with the AUG at the beginning of the CAT open reading frame.
c The ATG of preS2 was changed to CTG.
cultures which, unlike cell lines, appear to support a full early promoter upstream of the chloramphenicol acetyl-
transferase (CAT) gene, and pCAT-b lacks enhancer andcycle of WHV replication (Theze et al., 1987; Aldrich et
al., 1989), but are refractory to transfection by standard promoter elements. With pCAT-c, transcription of the CAT
gene is directed by the SV40 early promoter and en-protocols (unpublished observations).
hancer. Representative publications describing the HBV
elements are listed in Table 1.MATERIALS AND METHODS
To test for enhancer activity, the HBV sequences con-
Plasmids. Cloned WHV (Kodama et al., 1985) and taining the E1 (Shaul, 1992) and E2 (Yee, 1989; Wang et
HBV (Valenzuela et al., 1980) were obtained from C. al., 1990) elements of HBV (Table 1) were inserted into
Seeger (Fox Chase Cancer Center) and D. Ganem (Uni- pCAT-p at a BamHI site downstream from the CAT gene,
versity of California, San Francisco, CA), respectively. in the antisense orientation. (The E2 5* boundary em-
Regions of each (Table 1) were amplified by the poly- ployed in our studies follows work published by several
merase chain reaction (PCR) using oligonucleotide laboratories (e.g., Yee, 1989; Wang et al., 1990), and ex-
primers containing suitable restriction enzyme sites cludes sequences reported by others to be essential for
and subcloned as described under Results. The loca- E2 enhancer activity (Yuh and Ting, 1990).) The homolo-
tions of transcriptional regulatory elements of WHV for gous regions of WHV (Table 1) were inserted in pCAT-p
subsequent amplification and subcloning were pre- downstream from the CAT gene in the antisense orienta-
dicted by alignment with HBV (adw subtype). The first tion, between PstI and XbaI restriction endonuclease
nucleotide of the core gene was defined as map posi- sites, or upstream of the CAT gene in pCAT-p, in both
tion 1. For construction of chimeras between the en- sense and antisense orientations, at a BglII site.
hancer I (E1) region of HBV and the homologous region To test for promoter activity of HBV and WHV se-
of WHV, we used a PCR method, gene splicing by over- quences, and for the effect of enhancer regions on vari-
lap extension (SOE), an approach for recombining het- ous promoters, pCAT-b was used. Presumptive promoter
erologous nucleotide sequences at precise junctions fragments of WHV were inserted into pCAT-b, upstream
without reliance on restriction endonuclease sites of the CAT gene, between PstI and SalI sites. WHV se-
(Horton et al., 1989, 1990). Within the E1 regions of quences were then evaluated for enhancer activity on the
HBV and WHV, there were two regions with identical various promoters following insertion, in the antisense
sequence which were utilized as junctions in the pro- orientation, at a HindIII site upstream from the promoter,
duction of E1 chimeras via SOE. The identical se- or at a BamHI site downstream from the CAT gene in
quences were 5*-TTAATGCCTTTGTAT-3*, from WHV sense and antisense orientation. Promoter fragments of
nucleotides 2480 to 2494 and HBV nucleotides 2372 HBV were inserted into pCAT-b at HindIII and SalI sites
to 2386, and 5*-GTGTTTGCTGACGCAACCCCCAC- upstream of the CAT gene. HBV enhancer fragments
TGG-3*, from WHV nucleotides 2609 to 2634 and HBV were inserted into pCAT-b, in the antisense orientation,
nucleotides 2501 to 2526. at the HindIII site upstream of the promoter element or
The plasmids used for mapping and characterization at the BamHI site downstream of the CAT gene.
of the enhancer and promoter elements of WHV were The pUC8-derived plasmid, pTKCAT, containing the
herpes simplex virus minimum thymidine kinase pro-obtained from Promega, Inc. pCAT-p contains an SV40
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moter (McKnight and Kingsbury, 1982) followed by the normalized to a defined amount of protein in the cell
lysates for each assay.CAT-coding sequences and the SV40 polyadenylation se-
quences was provided by Dr. G. Schultz (German Cancer
Research Center, Heidelberg, Germany). The fragments RESULTS
of WHV and HBV containing the E1 region were inserted
WHV contains an E2 enhancer but lacks a homologueinto the BamHI site of pTKCAT in the sense and anti-
to the E1 enhancer of HBV. HBV enhancers 1 and 2 (Tablesense orientations.
1) have been characterized using a variety of liver cellTransfections and CAT assays. Transient transfections
lines, including HepG2, Huh7, Huh6, Alexander (PLC/were carried out with the human liver derived cell lines
PRF/5), and Hep-SK. The overall nucleotide sequenceHepG2 (Knowles et al., 1980), Huh6, and Huh7 (Nakabay-
alignment of WHV (Kodama et al., 1985) and HBV (Valen-ashi et al., 1982). Cell lines were cultured in Dulbecco’s
zuela et al., 1980) reveals 59% similarity between the twomodified Eagle’s medium-F12 supplemented with 10%
viral genomes. The similarity between E1 of HBV and thefetal bovine serum and antibiotics. Transfections were
corresponding region of WHV is 62%, and between thecarried out at 1–2 days postseeding, when the mono-
E2 regions, 57%. Sequence scanning in the E1 homologylayers were about 70% confluent.
region, the most studied of the two HBV enhancers (Fig.DNA for transient transfection of cells was prepared
1A), revealed both conservation and possible loss of fac-using a QIAGEN plasmid purification kit (QIAGEN Inc.,
tor binding sites, at least as defined with HBV, and didChatworth, CA) following the manufacturer’s instructions.
not clearly predict whether the region would function asTransfection of monolayers on 60-mm-diameter tissue
an enhancer. Sequence scanning through the E2 homol-culture dishes was carried out using a calcium phos-
ogy region, which was recently reported to contain anphate precipitation method (van der Eb and Graham,
enhancer (Ueda et al., 1996), would also have failed to1980). Unless noted, 5 mg of test plasmid per 60-mm-
predict whether this sequence would be a functional en-diameter petri dish was cotransfected with 1 mg of
hancer (Fig. 1B). Therefore, to determine if the E1 regionpBC12/RSV/SEAP, which was included as an internal
of the WHV genome can function as an enhancer, andcontrol. pBC12/RSV/SEAP (provided by B. Cullen, Duke
to further evaluate E2, various regions were tested for
University, Durham, NC) directs expression of secreted
enhancer activity. As a first step, we assayed for activa-
alkaline phosphatase (SEAP) from an RSV LTR promoter
tion of the SV40 early promoter in HepG2 cells. As sum-
(Berger et al., 1988). For CAT assays, transfected cultures
marized in Fig. 2, the region of WHV spanning E1 and
were harvested at 66–70 hr after transfection.
E2, from nt 2392 to 3251, activated the SV40 early pro-
CAT levels were measured essentially as described moter about 10-fold when inserted upstream in either the
(Gorman et al., 1982). The transfected cells were washed sense or antisense orientation. Experiments were then
three times with PBS and treated with 1 ml of 150 mM carried out to determine if E1, as well as E2, had en-
NaCl, 40 mM Tris–HCl, pH 8.0, 10 mM EDTA at room hancer activity.
temperature for 5 min. The cells were then harvested In agreement with results obtained by another labora-
and centrifuged at 12,000 g for 2 min. The cell pellets tory (Ueda et al., 1996), the E2 region of WHV, from nt
were resuspended in 100 ml of 0.25 M Tris–HCl, pH 8.0, 3101 to 3251 (Table 2, Fig. 2), functioned as a strong
subjected to 3 freeze/thaw cycles, and then incubated at enhancer, activating the SV40 early promoter in an orien-
657 for 10 min. The cell lysates were clarified by centrifu- tation and position independent fashion. Deletion of 24
gation at 12,000 g for 5 min. The supernatants were as- nucleotides (3228 to 3251) spanning the pregenome initi-
sayed for CAT activity. For each reaction the cell extract ation site (nt 3234) at the 3* end of this region had essen-
was incubated with 0.15 mCi of [14C]chloramphenicol and tially no effect on enhancer activity, but deletion of 42
20 ml of 4 mM acetyl coenzyme A at 377 for 1 hr. Chroma- nucleotides (3101 to 3142) from the 5* end resulted in a
tographs were quantitatively scanned using a radioana- loss of activity. This deletion eliminates WHV sequences
lytic imaging system (AMBIS). The percentage conver- homologous to a region which appears to contain an
sion of CAT is the mean value of assays performed in HNF3 binding site, and perhaps other liver-specific factor
triplicate, with measurements made in the linear range binding sites essential for the activity of the HBV E2
of the assay. The CAT activity of pCAT-p was set as 1. element (Chen et al., 1993; Johnson et al., 1995; Li et al.,
The CAT activity of each construct was compared with 1995). Addition of upstream sequences to E2, from nt
that of pCAT-p. SEAP levels in culture fluids from trans- 2828 to 3101, reduced enhancer activity. A negative effect
fected cells were measured by a colorimetric assay, as of adding upstream sequences to the E2 element has
described (Berger et al., 1988). The change in absor- been found for HBV (Spandau and Lee, 1988; Yee, 1989;
bency was plotted and the linear reaction rate was deter- Lo and Ting, 1994).
mined. CAT assays were carried out with amounts of In contrast to the E2 region, a DNA fragment spanning
extract that were normalized to a defined amount of SEAP the predicted E1 region of the WHV genome (nt 2392 to
2798, Table 1) failed to activate the SV40 early promoteractivity in culture fluids. The CAT activity was further
AID VY 8422 / 6a29$$$342 02-13-97 14:18:56 vira AP: Virology
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in HepG2 cells (Table 2, Fig. 2). Moreover, no enhancer
activity was detected with a smaller WHV DNA fragment
extending from nt 2539 to 2655 and homologous to the
minimal enhancer region reported by Ben-Levy et al.,
1989) or with two larger fragments encompassing part
or all of the E1 region (nt 1941 to 2798 and nt 1941 to
2522) (Fig. 2).
In addition to HepG2, two other liver cell lines, Huh6
and Huh7, have been widely used to study expression
of HBV (Knowles et al., 1980; Sureau et al., 1986; Tsuri-
moto et al., 1987). We therefore compared various con-
structs containing the E1 or E2 elements of HBV, or the
corresponding regions of WHV, in all three cell lines. As
shown in Table 2, the E1 region of WHV failed to activate
the SV40 early promoter element in all three cell lines.
We also tested for the ability of this region to activate
the HSV TK-promoter (McKnight and Kingsbury, 1982).
Again, no activation was observed with the WHV E1 se-
quence, while the E1 fragment of HBV activated this pro-
moter (data not shown).
To determine if either the putative WHV E1 or E2 re-
gions can activate WHV promoters, relatively large ge-
nome fragments spanning regions of WHV homologous
to the major promoters of HBV were cloned into pCAT-
b, which lacks promoter and enhancer elements. The
core promoter that was tested for activation by E1 lacked
sequences essential for the activity of the partially over-
lapping WHV E2 enhancer. Modest levels of CAT expres-
sion were detected with the WHV S (nt 1028 to 1595), X
(nt 2539 to 2798), and C (nt 3143 to 3251) promoter con-
structs (Tables 3 and 4); no expression was detected
with the PreS promoter construct (nt 589 to 968). To test
for enhancer activity, the WHV E2 element was placed
upstream of the WHV promoters, in an antisense orienta-
tion. The WHV E1 element was tested in both upstream
and downstream positions. E2 activated the PreS, S, and
X promoters (Table 3). E1 was unable to activate any
viral promoter from the downstream position (Table 4).
The WHV S promoter appeared to be activated, however,
when the WHV E1 sequence was placed immediately
upstream. The HBV E1 element activated both the PreS1
and S promoters of HBV. The HBV S promoter, like the
WHV S promoter, appeared to be slightly activated when
the WHV E1 sequence was placed upstream. Nonethe-
less, the inability of the WHV E1 sequence to activate
several viral and nonviral promoters and its inability to
activate the S promoter except from the upstream posi-
tion argue against the idea that an enhancer element is
contained in this region.
To further evaluate the ability of sequence elements to
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activate the promoters of WHV, the E1 sequences of WHV
and HBV were exchanged in some of the promoter con-
structs described above (Table 4). The E1 element of HBV
activated the S and C promoters of WHV. Thus, the failure
of these promoters to respond to the WHV E1 sequence is
a property of this sequence, and not of the promoters.
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FIG. 2. The region of the WHV genome homologous to enhancer 1 of HBV was not functional in HepG2 cells. The location of open reading
frames on the WHV genome are shown at the top, along with the regions homologous to enhancers 1 (E1) and 2 (E2) of HBV. The ability of various
E1- and E2-containing constructs to activate expression from the SV40 early promoter was determined in HepG2 cells. CAT activity was measured
as described under Materials and Methods, and is normalized to the activity of the enhancerless control, CATp (SV40 early promoter), which was
assigned a value of 1. ND, not done.
Next, we asked if the E1 sequences influenced the C HBV (from nt 2284 to 2698) activated the CAT expression
level when compared to the E2/C promoter alone.promoter of WHV when in their natural upstream position
Subdomains of the HBV enhancer cannot be replacedand orientation. As summarized in Table 5, an enhancer/
by homologous regions from the E1 region of WHV. Thepromoter construct which contained the entire E1–E2–
enhancer I of HBV has been reported to be divisible intoC region of WHV, from nt 2392 to 3251, was less active
three distinct functional domains (Dikstein et al., 1990a;transcriptionally than one containing only the E2–C pro-
Trujillo et al., 1991): a modulatory domain, a core en-moter (cf., Fig. 1); in contrast, the homologous region of
hancer domain (referred to as the minimal enhancer by
Ben-Levy et al. (1989)), and a basal X promoter domain.
TABLE 2 Interestingly, the two sequences that seem to delineate
Comparison of the E1 and E2 Regions of WHV and HBV these three domains within HBV E1 are conserved be-
in Liver Cell Linesa tween WHV and HBV. When aligning the E1 region of
HBV with that of WHV, the following sequences are ap-
Relative CAT activity
parent at the boundaries of these domains: 5*-TTAATG-
CCTTTGTAT-3* (WHV nt 2480 to 2494; HBV nt 2372 toHBV HBV WHV WHV
Cells E1 E2 E1 E2 CATc 2386) and 5*-GTGTTTGCTGACGCAACCCCCACTGG-3*
(WHV nt 2609 to 2634; HBV 2501 to 2526). Utilizing these
HepG2 31 10 2 18 8.8 sequences, we dissected the E1 region of each virus into
Huh6 80 74 1.2 73 75 three parts: a 5* domain corresponding to the modulatoryHuh7 47 3.7 1.4 8.8 37
domain, a middle domain corresponding to the enhancer
core, and a 3* domain corresponding to the basal X pro-a CAT activity was measured as described under Materials and Meth-
ods, and is normalized to the activity of the enhancerless control, CATp moter domain. The WHV and HBV domains were joined
(SV40 early promoter), which is assigned a value of 1. Results are to produce WHV–HBV E1 chimeras and the enhancer
presented for the WHV E1 (2392 – 2798) and E2 (3101–3251) sequences activity of each was determined in Huh7 and HepG2
placed downstream of the CAT reporter gene (Fig. 1), and for the
cells.homologous HBV constructs (E1(2284–2690) and E2(2998–3155)). In-
In HepG2 cells, constructs containing the HBV en-serts were in the antisense orientation. CATc contains the SV40 en-
hancer in the downstream position. hancer core and either upstream or downstream se-
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TABLE 3 TABLE 5
The Effect of the E2 Region of WHV on PreS, S, and X Promoters The E1 Region of WHV Did Not Activate the WHV Core Promoter
in HepG2 Cellsain HepG2 Cellsa
Relative CAT activity Relative CAT
Promoter/enhancer coordinates activity
No
Promoter enhancer E2 WHV C (3143–3251) 2
WHV E2/C (3101–3251) 40
WHV E1–E2/C (2392–3251) 10WHV
HBV E2/C (2998–3155) 9.3
None Backgroundb 1.5 HBV E1–E2/C (2284–3155) 51
PreS Background 8.1
S 2.0 47 a CAT activity was measured as described under Materials and Meth-
X 4.4 42 ods, and is normalized to the activity of CATp (SV40 early promoter),
which was assigned a value of 1.
HBV
None Backgrounda 1.1
PreS 4.8 6.1
the WHV element in these cells. Figure 1 illustrates thatS 3.4 13
sequence differences between WHV and HBV were scat-
a The results are shown for activation of promoters derived from the tered through the entire E1 region. This comparison
same virus. shows that many of the sequences which served as tran-
b The plasmid pCAT-b without promoter and enhancer was used as scription factor binding sites in HBV are clearly not con-
a negative control. The activity of CAT-b was at background.
served in WHV. Examples include several C/EBP binding
sites (Patel et al., 1989; Dikstein et al., 1990b; Trujillo et
al., 1991), three NF1 sites (NF1a–c) (Ben-Levy et al., 1989;quences from WHV were as active as the HBV E1 en-
hancer construct, but substitution of both upstream and Dikstein et al., 1990a; Ori et al., 1994), one of two HNF3
sites (Ori and Shaul, 1995), and an RAR site (Garcia etdownstream domains reduced enhancer activity (Fig. 3).
In contrast, none of the three regions of WHV was able al., 1993b; Huan et al., 1995). However, some sites in the
predicted E1 region of WHV appear to be conserved: EF-to substitute for the respective regions of HBV in Huh7
cells. Therefore, the E1 region of WHV contains multiple C/EP (Ben-Levy et al., 1989; Huan and Siddiqui, 1992;
Garcia et al., 1993b; Siegrist et al., 1993), HNF3 (Ori anddifferences to E1 of HBV scattered throughout. As men-
tioned earlier, direct examination of the two sequences Shaul, 1995), and E (Ap-1) (Shaul and Ben, 1987; Faktor
and Shaul, 1990).provides at least some rationale for a lack of activity of
TABLE 4
Effect of E1 on PreS, S, X, and C Promoters in HepG2 Cellsa
Relative CAT activity b
WHV HBV
Promoter No enhancer E1 (D) E1 (U) E1 (D) E1 (U)
WHV
No promoter Background 0.6 0.9 1.2 4.6
PreS (589–968) Background 0.5 0.3 NDc 0.2
S (1028–1595) 2.0 3.5 13 ND 17.5
X (2490–2799) 4.4 2.7 5.6 ND 10.9
C (3143–3251) 2.0 ND 1.5 ND 27.7
HBV
PreS (583–953) 4.8 ND 4.2 17 73
S (980–1475) 3.4 ND 8.9 8.9 17
a Results are from the same experiment as Table 3.
b The activity of E1 was assessed in upstream (U) and downstream (D), antisense, orientations.
c Not done.
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FIG. 3. Chimeras of HBV E1 and the homologous region of WHV had reduced enhancer activity in HepG2 and Huh7 cells. The ability of chimeric
enhancers to activate expression from the SV40 early promoter when present in the downstream, antisense orientation, was determined as described
under Materials and Methods. CAT activity was normalized to the activity of the enhancerless control, CATp, which was assigned a value of 1.
Effect of deleting apparently conserved factor binding 2791 are also essential for X promoter activity (Fig. 1A).
Therefore, a minimal X promoter appears to span fromsites in the E1 region of WHV on X promoter activity.
Assuming that woodchuck transcription factors would ca. nt 2658 to 2791.
Both our results and those of Sugata et al. (1994) indi-have sequence specificity in common with those from
other, more thoroughly studied species, one possible cate that sequences mapping upstream of nt 2660 aug-
ment X promoter activity. Our results suggest that someexplanation for the conservation of some transcription
factor binding sites in the E1 region of the WHV genome of these sequences map between nt 2577 and 2607.
However, neither study reveals whether additional con-might be that it also defines part of the X gene promoter.
In fact, a recent study reported that the X gene promoter served sequences in the E1 homology region augment
the X promoter, and whether the apparent conservationactivity was partially dependent on sequences mapping
upstream of nt 2660 (Sugata et al., 1994) (Fig. 1A). We of many of the factor binding sites in this region of HBV
is indicative of a functional role in WHV transcriptiontherefore examined the effects on X promoter activity
in HepG2 cells of deleting several conserved upstream remains unclear. This may be resolved as consideration
regions (cf. Table 6 and Fig. 1A). Deletion of 38 bp, from
2539 to 2576 on the WHV genome, had no effect on X
TABLE 6promoter activity (Fig. 1A), which was perhaps not sur-
prising, since the HNF3 and RARE binding sites found Mapping of the Minimal X-Gene Promotera
in HBV were apparently not conserved in WHV. Deletion
Promoter coordinates Relative CAT activityof an additional 30 bp, from 2577 to 2607, a region con-
taining a consensus EF–C binding site, produced a
2539–2799 4.4
slight, twofold reduction in X promoter activity. Deletion 2577–2799 3.6
to nt 2630, which removes a potential HNF-3 binding site, 2607–2799 2.4
2630–2799 1.8as well as a deletion to 2658, which would remove an NF-
2658–2799 2.11 binding site, did not further reduce X promoter activity.
2692–2799 BackgroundDeletion to nt 2692 reduced the promoter activity to back-
ground. Therefore, a minimal X promoter includes se- a CAT activity was measured in HepG2 cells as described under
quences mapping between nt 2658 and 2692. Sugata et Materials and Methods, and is normalized to the activity of CATp (SV40
early promoter), which was assigned a value of 1.al. (1994) have obtained evidence that nucleotides 2782 –
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is given in the future to a wider range of liver cell lines sion may have been incomplete because virtually all of
the extracellular particles have the characteristics of viralor primary hepatocyte cultures which may display more
liver-like functions than the cell lines used in our experi- cores rather than enveloped virus (unpublished observa-
tions). Therefore, why WHV expression is deficient inments.
cell lines and how this deficiency can be overcome still
remain to be determined. This, in turn, raises the possibil-DISCUSSION
ity that some of the characteristics of transcriptional reg-
ulation (e.g., lack of an active E1; apparent conservationThe transcriptional activities of WHV sequence ele-
ments were compared with regions of HBV already of factor binding sites in the E1/X promoter region) may
be defined, with greater biological relevance, as moreknown to have such activity. Our experiments confirmed
the existence on WHV of a functional E2 enhancer ele- suitable host cells become available or as studies are
extended to directly analyze transcriptional control ofment (Yee, 1989; Yuh and Ting, 1990; Wu et al., 1992).
This interpretation is supported by studies of N-myc acti- WHV within the liver. A suitable cell culture system for
expression of WHV from transfected DNA could also takevation via WHV insertional mutagenesis (Ueda et al.,
1996). Using CAT expression as a marker of transcription, advantage of primary hepatocyte cultures, which are sus-
ceptible to WHV infection (Theze et al., 1987; Aldrich etwe were able to obtain evidence that E2 can activate
transcription from the WHV C, PreS, S, and X promoters. al., 1989), and allow a genetic analysis of virus replica-
tion, similar to that which has been achieved with duckIn accord with results obtained for HBV (Honigwachs et
al., 1989; Yee, 1989; Yuh and Ting, 1990; Su and Yee, hepatitis B virus.
1992), the E2 enhancer region of WHV was found to
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